D. Menzies
Infectious Diseases · 2003–2020
A researcher in the Science corpus: 9 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Infectious Diseases — 34 citations into it
- Epidemiology — 17 citations into it
- Surgery — 16 citations into it
Whom D. Menzies trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from D. Menzies's perspective
Ordered by how strongly the researchers D. Menzies trusts endorse each paper. Same corpus, a different order for every researcher.
- Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. (New England Journal of Medicine)
- False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? (The International Journal of Tuberculosis and Lung Disease)
- Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for ResearchMenzies D, Pai M, Comstock G (McGill Univ, Montreal; Johns Hopkins…
- Logistic Regression: A Self-Learning Text
- The Commonality of Risk Factors for Nosocomial Colonization and Infection with Antimicrobial-Resistant Staphylococcus aureus, Enterococcus, Gram-Negative Bacilli, Clostridium difficile, and Candida (Annals of Internal Medicine)
- Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. (Clinical Infectious Diseases)
- Cancer Statistics, 2011: The Impact of Eliminating Socioeconomic and Racial Disparities on Premature Cancer Deaths
- How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General
- Global cancer statistics (Ca)
- Treating Tobacco Use and Dependence: 2008 Update
Their papers
- Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis (2020) — 797 citations
- The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. (2017) — 627 citations
- Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries (2015) — 598 citations
- Three months of rifapentine and isoniazid for latent tuberculosis infection. (2011) — 875 citations
- Systematic Review: T-Cellbased Assays for the Diagnosis of Latent Tuberculosis Infection: An Update (2008) — 1,431 citations
- Tuberculosis among Health-Care Workers in Low- and Middle-Income Countries: A Systematic Review (2006) — 610 citations
- False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? (2006) — 689 citations
- Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case–control studies (2004) — 598 citations
- Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis. (2003) — 858 citations